Medford (541) 770-2020

Grants Pass (541) 956-2020

Email Us

Patient Portal

Reputable Clinical Studies

Send A Message

Dedicated to Certified Research

As qualified and committed retina eye doctors, we strive to deliver the highest level of care for all retina-related eye conditions. The Oregon Retina Center in Medford & Grant Pass, OR, is dedicated to providing cutting-edge medical care from carefully performed research and studies.

Our numerous FDA-approved clinical trials allow us to provide our patients with the most advanced care. As the retina field of study expands, we do our best to continue breaking bounds and researching better treatments and less intrusive methods.


Clinical Trials

Nonvascular Age-related Macular Degeneration (Wet AMD)

Chengdu Kanghong “Panda2” (Currently Enrolling)
A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Degeneration.

Geographic Atrophy (Dry AMD)

Apellis “DERBY” (Enrollment Coming Soon)
A Phase III, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Non-proliferative Diabetic Retinopathy

Regeneron PANORAMA (Enrollment No Longer Open)
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)
Phase 3 Study. This study will assess the efficacy of intravitreal aflibercept (Eylea) in participants with moderately severe to severe nonproliferative diabetic retinopathy.

Retinal Vein Occlusion

Clearside “SAPPHIRE” (Closed) 
Study of the safety and efficacy of Suprachoroidal CLS-TA in conjunction with intravitreal aflibercept (Eylea) in the treatment of retinal vein occlusion.
Phase 3 Study. This study will evaluate the combination of Suprachoroidal CLS-TA and Eylea in improving best-corrected visual acuity in patients with retinal vein occlusion.

Age-Related Macular Degeneration Research

Roche “AVENUE” (Closed)
A Proof-of-Concept Study of RG7716 in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD). Phase 2 Study. This study will evaluate the safety, tolerability, pharmacokinetics, and efficacy of RG7716 in participants with subfoveal CNV secondary to AMD.

Diabetic Macular Edema (DME)

Clearside “TYBEE” (Closed)
Randomized, Double Masked, Controlled Study Comparing the Safety and Efficacy of Suprachoroidal CLS-TA with Intravitreal Aflibercept versus Aflibercept alone in Subjects with Diabetic Macular Edema.

For a status update on our current trials or to learn more, please call our Research Department at (541) 770-2020.

Oregon Retina Center


1518 E Barnett Rd
Medford, OR 97504

(541) 770-2020


Write us a review

Grants Pass

1867 Williams Hwy
Grants Pass, OR 97527

(541) 956-2020


Write us a review

Contact Info
Business Hours:
Monday - Friday: 8:00 AM - 5:00 PM

Oregon Retina Center in Medford & Grants Pass, OR

Proudly Serving Southern Oregon Communities

Jackson, Josephine, The Applegates, Ashland, Butte Falls, Central Point, Cave Junction, Eagle Point, Grants Pass, Jacksonville, Lake Creek, Medford, Merlin, Murphy, Phoenix, Prospect, Provolt, Rogue River, Ruch, Sams Valley, Shady Cove, Sunny Valley, Talent, Trail, White City, Williams, Wolf Creek